Literature DB >> 93110

[Concentrations of cytostatic drugs in organs and tumors: comparison after intravenous and intratumoral injection (author's transl)].

M Wenzel, M Schneider, J Bier, P Benders, G Schachschneider.   

Abstract

The cytostatic drugs Chlorambucil and Bleomycin were labeled with 131I and with 57Co, respectively: Ruthenocenealdehyde-(N-methyl-N-beta-chlorethyl)-hydrazone and Ruthenocene-3-phenyl-prop.1-en-3-one were labeled with the gamma emitter 103Ru. In tumor-bearing mice the elimination and organ distribution of these radioactive substances were tested after intravenous (i.v.) and intratumoral (i.t.) injection of the drugs. The organ load showed lower values after i.t. than after i.v. application, while the radioactivity concentrations in the tumor were considerably increased after i.t. injection. The integrals of the concentration-time curves showed 10--80 times higher concentrations in the tumor after i.t. compared to i.v. injection of the drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93110     DOI: 10.1007/bf00401009

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  9 in total

1.  Synthesis of tritium-labeled chlorambucil and aniline mustard of high specific activity.

Authors:  M Jarman; L J Griggs; M J Tisdale
Journal:  J Med Chem       Date:  1974-02       Impact factor: 7.446

2.  Cobalt chelate of bleomycin. I. Physicochemical properties and distribution in tumor bearing mice.

Authors:  A Kono; Y Matsushima; M Kojima; T Maeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1977-07       Impact factor: 1.645

3.  Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.

Authors:  R C Bast; M Segerling; S H Ohanian; S L Greene; B Zbar; H J Rapp; T Borsos
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

4.  The fate of [103Ru]ruthenocene in mice and rats.

Authors:  A J Taylor; M Wenzel
Journal:  Xenobiotica       Date:  1978-02       Impact factor: 1.908

5.  [Tumor affinity of 103 Ru-ruthenocen-derivatives and 67gallium citrate].

Authors:  M Wenzel
Journal:  Strahlentherapie       Date:  1978-07

6.  [Biochemistry of metallocenes, II. Organ-distribution and thymus affinity of cinnamoyl-[103Ru]ruthenocene (author's transl)].

Authors:  M Wenzel; R Herken; W Klose
Journal:  Z Naturforsch C Biosci       Date:  1977 Jul-Aug

7.  Biochemistry of metalocenes. I. Distribution of 59Fe or 103Ru-labeled metalocene carboxylic acid in mice.

Authors:  M Wenzel; E Nipper; W Klose
Journal:  J Nucl Med       Date:  1977-04       Impact factor: 10.057

8.  Attempt at local administration of anticancer agents in the form of fat emulsion.

Authors:  T Takahashi; S Ueda; K Kono; S Majima
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

9.  Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.

Authors:  K A Krohn; J M Meyers; G L DeNardo; S J DeNardo
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

  9 in total
  2 in total

1.  Intratumoural administration of cisplatin in slow-release devices. I. Tumour response and toxicity.

Authors:  M J Deurloo; S Bohlken; W Kop; C F Lerk; W Hennink; H Bartelink; A C Begg
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.

Authors:  M J Deurloo; W Kop; O van Tellingen; H Bartelink; A C Begg
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.